1.91 USD
-0.02 (-1.04%)
At close: Sep 10, 2025
1.94 USD
+0.03 (+1.57%)
After Hours: 9/10/2025, 8:00:01 PM
We assign a fundamental rating of 2 out of 10 to DRRX. DRRX was compared to 190 industry peers in the Pharmaceuticals industry. While DRRX seems to be doing ok healthwise, there are quite some concerns on its profitability. DRRX is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- DRRX had negative earnings in the past year.
- DRRX had a negative operating cash flow in the past year.
- DRRX had negative earnings in each of the past 5 years.
- DRRX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- DRRX has a Return On Assets (-27.86%) which is in line with its industry peers.
- DRRX has a Return On Equity (-99.86%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.86% | ||
| ROE | -99.86% | ||
| ROIC | N/A |
ROA(3y)-55.09%
ROA(5y)-41.09%
ROE(3y)-139.78%
ROE(5y)-96.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- DRRX has a Gross Margin of 62.60%. This is in the better half of the industry: DRRX outperforms 70.56% of its industry peers.
- DRRX's Gross Margin has been stable in the last couple of years.
- DRRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 62.6% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.8%
GM growth 5Y0.25%
2. Health
2.1 Basic Checks
- DRRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- DRRX has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, DRRX has more shares outstanding
- There is no outstanding debt for DRRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -67.96, we must say that DRRX is in the distress zone and has some risk of bankruptcy.
- With a Altman-Z score value of -67.96, DRRX is not doing good in the industry: 92.39% of the companies in the same industry are doing better.
- DRRX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -67.96 |
ROIC/WACCN/A
WACC10.88%
2.3 Liquidity
- A Current Ratio of 0.98 indicates that DRRX may have some problems paying its short term obligations.
- The Current ratio of DRRX (0.98) is worse than 80.71% of its industry peers.
- A Quick Ratio of 0.95 indicates that DRRX may have some problems paying its short term obligations.
- DRRX's Quick ratio of 0.95 is on the low side compared to the rest of the industry. DRRX is outperformed by 74.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.95 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 83.61% over the past year.
- DRRX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -62.89%.
- Measured over the past years, DRRX shows a very negative growth in Revenue. The Revenue has been decreasing by -39.51% on average per year.
EPS 1Y (TTM)83.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
Revenue 1Y (TTM)-62.89%
Revenue growth 3Y-47.43%
Revenue growth 5Y-39.51%
Sales Q2Q%-79.41%
3.2 Future
- Based on estimates for the next years, DRRX will show a very strong growth in Earnings Per Share. The EPS will grow by 60.95% on average per year.
- DRRX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 53.91% yearly.
EPS Next Y-105.89%
EPS Next 2Y-24.45%
EPS Next 3Y57.26%
EPS Next 5Y60.95%
Revenue Next Year-92.31%
Revenue Next 2Y-22.88%
Revenue Next 3Y45.1%
Revenue Next 5Y53.91%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for DRRX. In the last year negative earnings were reported.
- Also next year DRRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- DRRX's earnings are expected to grow with 57.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.45%
EPS Next 3Y57.26%
5. Dividend
5.1 Amount
- DRRX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
DURECT CORPORATION / DRRX FAQ
What is the ChartMill fundamental rating of DURECT CORPORATION (DRRX) stock?
ChartMill assigns a fundamental rating of 2 / 10 to DRRX.
What is the valuation status for DRRX stock?
ChartMill assigns a valuation rating of 1 / 10 to DURECT CORPORATION (DRRX). This can be considered as Overvalued.
How profitable is DURECT CORPORATION (DRRX) stock?
DURECT CORPORATION (DRRX) has a profitability rating of 1 / 10.
What is the financial health of DURECT CORPORATION (DRRX) stock?
The financial health rating of DURECT CORPORATION (DRRX) is 4 / 10.